Bibliography
- Labrie F. Extragonadal synthesis of sex steroids: intracrinology. Ann Endocrinol (Paris). 2003;64:95-107
- Matsuo K, Irie N. Osteoclast-osteoblast communication. Arch Biochem Biophys 2008;473:201-9
- Sims NA, Gooi JH. Bone remodeling: Multiple cellular interactions required for coupling of bone formation and resorption. Semin Cell Dev Biol 2008:444-51
- Henriksen K, Neutzsky-Wulff AV, Bonewald LF, Local communication on and within bone controls bone remodeling. Bone 2009;44:1026-33
- Rodan GA, Martin TJ. Therapeutic approaches to bone diseases. Science 2000;289:1508-14
- Simpson ER. Sources of estrogen and their importance. J Steroid Biochem Mol Biol 2003;86:225-30
- Gallagher JC. Advances in bone biology and new treatments for bone loss. Maturitas. 2008;60:65-9
- Vanderschueren D, Gaytant J, Boonen S, Androgens and bone. Curr Opin Endocrinol Diabetes Obes 2008;15:250-4
- Frank GR. Role of estrogen and androgen in pubertal skeletal physiology. Med Pediatr Oncol 2003;41:217-21
- Grumbach MM. Mutations in the synthesis and action of estrogen: the critical role in the male of estrogen on pubertal growth, skeletal maturation, and bone mass. Ann NY Acad Sci 2004;1038:7-13
- Compston JE. Sex steroids and bone. Physiol Rev 2001;81:419-47
- Manolagas SC, Kousteni S, Jilka RL. Sex steroids and bone. Recent Prog Horm Res 2002;57:385-409
- Syed F, Khosla S. Mechanisms of sex steroid effects on bone. Biochem Biophys Res Commun 2005;328:688-96
- Rauner M, Sipos W, Pietschmann P. Osteoimmunology. Int Arch Allergy Immunol 2007;143:31-48
- Hofbauer LC, Heufelder AE. Role of receptor activator of nuclear factor-kappaB ligand and osteoprotegerin in bone cell biology. J Mol Med 2001;79:243-53
- Wada T, Nakashima T, Hiroshi N, RANKL-RANK signaling in osteoclastogenesis and bone disease. Trends Mol Med. 2006;12:17-25
- Ando K, Mori K, Rédini F, RANKL/RANK/OPG: key therapeutic target in bone oncology. Curr Drug Discov Technol 2008;5:263-8
- Michael H, Härkönen PL, Väänänen HK, Estrogen and testosterone use different cellular pathways to inhibit osteoclastogenesis and bone resorption. J Bone Miner Res 2005;20:2224-32
- Centrella M, Christakos S, McCarthy TL. Skeletal hormones and the C/EBP and Runx transcription factors: interactions that integrate and redefine gene expression. Gene 2004;342(1):13-24
- Ray P, Ghosh SK, Zhang D-H, Ray A. Repression of interleukin-6 gene expression by 17beta-estradiol: inhibition of the DNA-binding activity of the transcription factors NF-IL6 and NF-κB by the estrogen receptor. FEBS Lett 1997;409:79-85
- McCarthy TL, Centrella M. Local IGF-I expression and bone formation. Growth Horm IGF Res 2001;11:213-9
- Teplyuk NM, Zhang Y, Lou Y, The osteogenic transcription factor runx2 controls genes involved in sterol/steroid metabolism, including CYP11A1 in osteoblasts. Mol Endocrinol 2009;23:849-61
- Weber KL. What's new in musculoskeletal oncology. J Bone Joint Surg Am 2005;87:1400-10
- Shirtcliff EA, Dahl RE, Pollak SD. Pubertal development: correspondence between hormonal and physical development. Child Dev 2009;80:327-37
- Rochira V, Carani C. Aromatase deficiency in men: a clinical perspective. Nat Rev Endocrinol 2009;5:559-68
- Grumbach MM. Estrogen, bone, growth and sex: a sea change in conventional wisdom. J Pediatr Endocrinol Metab 2000;13:1439-55
- Weber K, Damron TA, Frassica FJ, Malignant bone tumors. Instr Course Lect 2008;57:673-88
- O'Day K, Gorlick R. Novel therapeutic agents for osteosarcoma. Expert Rev Anticancer Ther 2009;9:511-23
- Cerase A, Priolo F. Skeletal benign bone-forming lesions. Eur J Radiol 1998;27:S91-7
- Zehetgruber H, Bittner B, Gruber D, Prevalence of aneurysmal and solitary bone cysts in young patients. Clin Orthop Relat Res 2005;439:136-43
- White LM, Kandel R. Osteoid-producing tumors of bone. Semin Musculoskelet Radiol 2000;4:25-43
- Dahlin DC, Cupps RE, Johnson EW Jr. Giant-cell tumor: a study of 195 cases. Cancer 1970;25:1061-70
- Thomas DM, Skubitz KM. Giant cell tumour of bone. Curr Opin Oncol 2009;21:338-44
- Labrie F, Luu-The V, Bélanger A, Is dehydroepiandrosterone a hormone? J Endocrinol 2005;187:169-96
- Grow DR. Metabolism of endogenous and exogenous reproductive hormones. Obstet Gynecol Clin North Am 2002;29:425-36
- Sasano H, Suzuki T, Miki Y, Intracrinology of estrogens and androgens in breast carcinoma. J Steroid Biochem Mol Biol 2008;108:181-5
- Miller WL. Steroidogenic enzymes. Endocr Dev 2008;13:1-18
- Bruch HR, Wolf L, Budde R, Androstenedione metabolism in cultured human osteoblast-like cells. J Clin Endocrinol Metab 1992;75:101-5
- Saito H, Yanaihara T. Steroid formation in osteoblast-like cells. J Int Med Res 1998;26:1-12
- Sasano H, Nagasaki S, Miki Y, New developments in intracrinology of human breast cancer: estrogen sulfatase and sulfotransferase. Ann NY Acad Sci 2009;1155:76-9
- Pasqualini JR. The selective estrogen enzyme modulators in breast cancer: a review. Biochim Biophys Acta. 2004;1654:123-43
- Janssen JM, Bland R, Hewison M, Estradiol formation by human osteoblasts via multiple pathways: relation with osteoblast function. J Cell Biochem 1999;75:528-37
- Muir M, Romalo G, Wolf L, Estrone sulfate is a major source of local estrogen formation in human bone. J Clin Endocrinol Metab 2004;89:4685-92
- Labrie F, Simard J, Luu-The V, Structure and tissue-specific expression of 3 beta-hydroxysteroid dehydrogenase/5-ene-4-ene isomerase genes in human andrat classical and peripheral steroidogenic tissues. J Steroid Biochem Mol Biol 1992;41:421-35
- Simard J, Ricketts ML, Gingras S, Molecular biology of the 3beta-hydroxysteroid dehydrogenase/delta5-delta4 isomerase gene family. Endocr Rev 2005;26:525-82
- Doggrell SA. New findings with old drugs for osteoporosis. Expert Opin Pharmacother 2009;10:513-6
- McCarthy TL, Hochberg RB, Labaree DC, Centrella M. 3-ketosteroid reductase activity and expression by fetal rat osteoblasts. J Biol Chem 2007;282:34003-12
- de Gooyer ME, Kleyn GT, Smits KC, Tibolone: a compound with tissue specific inhibitory effects on sulfatase. Mol Cell Endocrinol 2001;183(1-2):55-62
- Falany JL, Macrina N, Falany CN. Sulfation of tibolone and tibolone metabolites by expressed human cytosolic sulfotransferases. J Steroid Biochem Mol Biol 2004;88:383-91
- Kuwano Y, Fujikawa H, Watanabe A, 3Beta-hydroxysteroid dehydrogenase activity in human osteoblast-like cells. Endocr J 1997;44:847-53
- Dong Y, Qiu QQ, Debear J, 17Beta-hydroxysteroid dehydrogenases in human bone cells. J Bone Miner Res 1998;13:1539-46
- Fujikawa H, Okura F, Kuwano Y, Steroid sulfatase activity in osteoblast cells. Biochem Biophys Res Commun 1997;231:42-7
- Jakob F, Siggelkow H, Homann D, Local estradiol metabolism in osteoblast- and osteoclast-like cells. J Steroid Biochem Mol Biol 1997;61:167-74
- Baker ME. Evolution of 17beta-hydroxysteroid dehydrogenases and their role in androgen, estrogen and retinoid action. Mol Cell Endocrinol 2001;171:211-5
- Luu-The V. Analysis and characteristics of multiple types of human 17beta-hydroxysteroid dehydrogenase. J Steroid Biochem Mol Biol 2001;76:143-51
- Meier M, Möller G, Adamski J. Perspectives in understanding the role of human 17beta-hydroxysteroid dehydrogenases in health and disease. Ann NY Acad Sci 2009;1155:15-24
- Penning TM, Byrns MC. Steroid hormone transforming aldo-keto reductases and cancer. Ann NY Acad Sci 2009;1155:33-42
- Stanbrough M, Bubley GJ, Ross K, Increased expression of genes converting adrenal androgens to testosterone in androgen-independent prostate cancer. Cancer Res 2006;66:2815-25
- Feix M, Wolf L, Schweikert HU. Distribution of 17beta-hydroxysteroid dehydrogenases in human osteoblast-like cells. Mol Cell Endocrinol 2001;171:163-4
- Osawa Y, Higashiyama T, Fronckowiak M, Aromatase. J Steroid Biochem 1987;27:781-9
- Simpson ER. Aromatase: biologic relevance of tissue-specific expression. Semin Reprod Med 2004;22:11-23
- Nawata H, Tanaka S, Tanaka S, Aromatase in bone cell: association with osteoporosis in postmenopausal women. J Steroid Biochem Mol Biol 1995;53:165-74
- Santen RJ, Brodie H, Simpson ER, History of aromatase: saga of an important biological mediator and therapeutic target. Endocr Rev 2009;30:343-75
- Yanase T, Suzuki S, Goto K, Aromatase in bone: roles of vitamin D3 and androgens. J Steroid Biochem Mol Biol 2003;86:393-7
- Pino AM, Rodríguez JM, Ríos S, Aromatase activity of human mesenchymal stem cells is stimulated by early differentiation, vitamin D and leptin. J Endocrinol 2006;191:715-25
- Ghosh D. Human sulfatases: a structural perspective to catalysis. Cell Mol Life Sci 2007;64:2013-22
- Reed MJ, Purohit A, Woo LW, Steroid sulfatase: molecular biology, regulation, and inhibition. Endocr Rev 2005;26:171-202
- Iwamori M. Estrogen sulfatase. Methods Enzymol 2005;400:293-302
- Falany CN. Enzymology of human cytosolic sulfotransferases. FASEB J 1997;11:206-16
- Blanchard RL, Freimuth RR, Buck J, A proposed nomenclature system for the cytosolic sulfotransferase (SULT) superfamily. Pharmacogenetics 2004;14:199-211
- Adjei AA, Weinshilboum RM. Catecholestrogen sulfation: possible role in carcinogenesis. Biochem Biophys Res Commun 2002;292:402-8
- Svoboda M, Thalhammer T, Aust S, Estrogen sulfotransferase (SULT1E1) expression in benign and malignant human bone tumors. J Surg Oncol 2007;95:572-81
- Qian YM, Sun XJ, Tong MH, Targeted disruption of the mouse estrogen sulfotransferase gene reveals a role of estrogen metabolism in intracrine and paracrine estrogen regulation. Endocrinology 2001;142:5342-50
- Otterness DM, Weinshilboum R. Human dehydroepiandrosterone sulfotransferase: molecular cloning of cDNA and genomic DNA. Chem Biol Interact 1994;92:145-59
- Issa S, Schnabel D, Feix M, Human osteoblast-like cells express predominantly steroid 5alpha-reductase type 1. J Clin Endocrinol Metab 2002;87:5401-7
- Kushlinskii˘ NE, Degtiar' VG, Babkina TV, Androgen metabolism in malignant and benign bone tumors. Bull Exp Biol Med 2000;1:78-80
- Imai Y, Nakamura T, Matsumoto T, Molecular mechanisms underlying the effects of sex steroids on bone and mineral metabolism. J Bone Miner Metab 2009;27:127-30
- Miki Y, Suzuki T, Hatori M, Effects of aromatase inhibitors on human osteoblast and osteoblast-like cells: a possible androgenic bone protective effects induced by exemestane. Bone 2007;40:876-87
- Solakidi S, Psarra AM, Sekeris CE. Differential distribution of glucocorticoid and estrogen receptor isoforms: localization of GRbeta and ERalpha in nucleoli and GRalpha and ERbeta in the mitochondria of human osteosarcoma SaOS-2 and hepatocarcinoma HepG2 cell lines. J Musculoskelet Neuronal Interact 2007;7:240-5
- Dohi O, Hatori M, Suzuki T, Sex steroid receptors expression and hormone-induced cell proliferation in human osteosarcoma. Cancer Sci 2008;99:518-23
- Saraiva PP, Teixeira SS, Conde SJ, The importance of hormone receptor analysis in osteosarcoma cells growth submitted to treatment with estrogen in association with thyroid hormone. Cell Biochem Funct 2008;26:107-10
- Sasano H, Uzuki M, Sawai T, Aromatase in human bone tissue. J Bone Miner Res 1997;12:1416-23
- Shozu M, Simpson ER. Aromatase expression of human osteoblast-like cells. Mol Cell Endocrinol 1998;139:117-29
- Olivera P, Perez E, Ortega A, Estrogen receptor expression in giant cell tumors of the bone. Hum Pathol 2002;33:165-9
- Oursler MJ, Pederson L, Fitzpatrick L, Human giant cell tumors of the bone (osteoclastomas) are estrogen target cells. Proc Natl Acad Sci USA 1994;91:5227-31
- Pasqualini JR, Chetrite GS. Recent insight on the control of enzymes involved in estrogen formation and transformation in human breast cancer. J Steroid Biochem Mol Biol 2005;93:221-36
- Stanway SJ, Delavault P, Purohit A, Steroid sulfatase: a new target for the endocrine therapy of breast cancer. Oncologist 2007;12:370-4
- Aidoo-Gyamfi K, Cartledge T, Shah K, Estrone sulfatase and its inhibitors. Anticancer Agents Med Chem 2009;9:599-612
- Mitrunen K, Hirvonen A. Molecular epidemiology of sporadic breast cancer. The role of polymorphic genes involved in oestrogen biosynthesis and metabolism. Mutat Res 2003;544:9-41